| Age |
Obtained through registration in electronic medical records in preliminary evaluation to surgery. Bleeding risk: elderly15-17
|
| Sex |
Obtained through registration in electronic medical records. Bleeding risk: male15,16 and female |
| Systemic arterial hypertension (SAH) |
Verified as a clinical diagnosis prior to surgery and previous pathological history recorded in the electronic medical records. Bleeding risk: occurrence17
|
| Diabetes Mellitus (DM) |
Verified as a clinical diagnosis prior to surgery and previous pathological history recorded in the electronic medical record. Bleeding risk: not characterized17
|
| Hemoglobin (Hb) Levels |
Obtained from the last laboratory test collected prior to surgery (up to 10 days) and recorded in the electronic medical record. Risk of bleeding: anemia present6. Reference values: Birth (18.0 ± 4.0 g/dL), 3 days (18.0 ± 3.0 g/dL), 1 month (14.0 ± 2.5 g/dL), 2 months (11.2 ± 1.8 g/dL), 3 to 6 months (12.6 ± 1.5 g/dL), 1 year (12.6 ± 1.5 g/dL), 2 to 6 years (12.6 ± 1.5 g/dL), 6 to 12 years (12.5 ± 1.5 g/dL)22 adult women (14.0 ± 2.0) and adult men (15.5 ± 2.0 g/dL). All adopted by HCFMB |
| Hematocrit (Ht) Levels |
Obtained from the last laboratory test collected prior to surgery (up to 10 days) and recorded in the electronic medical record. Bleeding risk: below 30 %15,17. Reference values: Birth (60 ± 15 %), 3 days (56 ± 11 %), 1 month (43 ± 10 %), 2 months (35 ± 7 %), 3 to 6 months (35 ± 5 %), 1 year (34 ± 4 %), 2 to 6 years (37 ± 3 %), 6 to 12 years (40 ± 5 %), adult women (41 ± 5 %)22 and adult men (47 ± 6 %). All adopted by HCFMB |
| Platelet Count (PLT) |
Obtained from the last laboratory test collected prior to surgery (up to 10 days) and recorded in the electronic medical record. Bleeding risk: below 150,000 cells/mm³17. Reference value adopted by HCFMB: 140,000 to 440,000 10³/mm³ |
| Prothrombin activation time |
Obtained from the last laboratory test collected prior to surgery (up to 10 days) and recorded in the electronic medical record. Bleeding risk: above 14 s17. Reference value adopted by HCFMB: above 14 s, approximately International Normalized Ratio > 1.2 |
| Activated partial thromboplastin time (APTT) |
Obtained from the last laboratory test collected prior to surgery (up to 10 days) and recorded in the electronic medical record. Bleeding risk: above 40 s17. Reference value adopted by HCFMB: above 40 s, with a normal ratio of ≥ 0.70 to 1.25; above > 1.25 |
| Antiplatelet therapy |
Verified in medication prescriptions prior to surgery (up to 5 days) recorded in the electronic medical record. Examples of medications: non-steroidal anti-inflammatory drugs (NSAIDs), such as acetylsalicylic acid (AAS), dipyrone and paracetamol; blood thinners, such as warfarin, heparin, and enoxaparin; and antiplatelet agents, such as ketoprofen, clopidogrel and cilostazol. Bleeding risk: non-interruption or interruption for <5 days before surgery11,16-18
|
| History of Covid-19 |
Obtained in the past history in the years 2020 and 2021 and prior to surgery. Registered in electronic medical records |
| Type of surgery performed |
Recorded in surgical map and electronic medical record. The surgeries analyzed were: Communication closure (intraventricular or interatrial); pacemaker implantation; valve prosthesis implantation; and myocardial revascularization. Risk of bleeding: when ECC is used16,17
|
| Classification as reoperation |
Record in surgical map and history prior to surgery recorded in electronic medical records. Risk of bleeding: when present16
|
| Need for Extracorporeal Circulation |
Registered in electronic medical record. Risk of bleeding: when ECC is used16,17
|
| Extracorporeal Circulation Time |
Obtained through electronic medical records after surgery. Bleeding risk: prolonged ECC, around 90-110 min15. Reference Value used by HCFMB: normal up to 90 min19
|
| Activated Clotting Time (ACT) |
Obtained through electronic medical records after surgery. Reference value used by HCFMB: normal between 80-120 s19
|
| Therapy with systemic hemostatic agents |
Recorded in electronic medical records with prescription from 5 days before surgery until 1 day after surgery. Medications: tranexamic-acid, epsilon-aminocaproic acid4,5,18,20
|